All News #Library
Rare Diseases
Entrada Therapeutics Authorized for ELEVATE-45-201 Study in EU
29 May 2025 //
GLOBENEWSWIRE
Entrada to Participate in Guggenheim Genomic Medicines & Rare Disease Conference
29 Mar 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support